Not applicableStudy completedNCT02561533What this trial is testingDetection of BRAF Mutation on FNAB From Papillary Thyroid CarcinomaWho this might be right forPapillary Thyroid Carcinoma University of Aarhus 53
Testing effectiveness (Phase 2)UnknownNCT05007938What this trial is testingBefotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung CancerWho this might be right forNon-Small Cell Lung Cancer Betta Pharmaceuticals Co., Ltd. 30
Not applicableNot Yet RecruitingNCT06834438What this trial is testingGene Therapy for Neurofibromatosis Type 2 (NF2) with ST002Who this might be right forNF2 Deficiency Cancer Institute and Hospital, Chinese Academy of Medical Sciences 9
Large-scale testing (Phase 3)UnknownNCT04055038What this trial is testingEfficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)Who this might be right forOvarian CancerOvarian NeoplasmsSerous Adenocarcinoma+3 more Blokhin's Russian Cancer Research Center 164
Early research (Phase 1)Active Not RecruitingNCT03264664What this trial is testingStudy of E7386 in Participants With Selected Advanced NeoplasmsWho this might be right forAdvanced Neoplasms Eisai Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249What this trial is testingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 731
Testing effectiveness (Phase 2)Looking for participantsNCT06124963What this trial is testingWX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 MutationsWho this might be right forGastric Type Adenocarcinoma (GAS) With STK11 Mutation Shanghai Jiatan Pharmatech Co., Ltd 20
Not applicableLooking for participantsNCT05914987What this trial is testingDetermining Individualized Cancer Therapy in Pancreatic CancerWho this might be right forPancreatic Neoplasms Medical College of Wisconsin 1,000
Not applicableUnknownNCT04112537What this trial is testingDermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation RelationshipWho this might be right forTuberous Sclerosis Complex University Hospital, Montpellier 90
Testing effectiveness (Phase 2)Study completedNCT02273739What this trial is testingStudy of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationWho this might be right forSolid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more Celgene 21
Not applicableLooking for participantsNCT06817694What this trial is testingCognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 GeneWho this might be right forBreast Cancer Susceptibility Gene (BRCA1) MutationBRCA2 MutationFear of Cancer Recurrence CHU de Quebec-Universite Laval 250
Testing effectiveness (Phase 2)UnknownNCT04179656What this trial is testingThe Basket Study of Pyrotinib Maleate for HER2-Postive Solid TumorWho this might be right forSolid TumorHER2 Gene MutationHER-2 Gene Amplification+1 more Tianjin Medical University Second Hospital 100
Not applicableNot Yet RecruitingNCT06726330What this trial is testingRisk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic CancerWho this might be right forTubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage III+2 more Centre Oscar Lambret 1,100
Testing effectiveness (Phase 2)UnknownNCT04989322What this trial is testingPembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLCWho this might be right forNsclcEGFR Activating MutationEGF-R Positive Non-Small Cell Lung Cancer+3 more Dr Joanne CHIU 46
Not applicableStudy completedNCT04640870What this trial is testingThe Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With AfatinibWho this might be right forNon Small Cell Lung CancerEGF-R Positive Non-Small Cell Lung CancerEGFR Gene Mutation Hellenic Cooperative Oncology Group 59
Testing effectiveness (Phase 2)UnknownNCT05290337What this trial is testingZR-CHOP in DLBCL With Specific Gene AbnormalityWho this might be right forDiffuse Large B Cell Lymphoma Fudan University 62
Early research (Phase 1)Looking for participantsNCT06813365What this trial is testingAssessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)Who this might be right forNonsmall-cell Lung Cancer Dizal Pharmaceuticals 300
Not applicableStudy completedNCT03471572What this trial is testingStudy to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaWho this might be right forOvarian Cancer AstraZeneca 240
Not applicableStudy completedNCT01505205What this trial is testingStudy on the Evolution of Genes Mutation Related With Gastrointestinal Stromal TumorsWho this might be right forFull Gene Sequences of c-KIT、PDGFRA and DOG1 Are Analyzed With the Screening-sequencing ApproachInvestigate the Characteristics and Variations Associated With the Different Gene Mutations of c-KIT、PDGFRA and DOG1 in GIST Patients Guangxi Medical University 60
Not applicableNot Yet RecruitingNCT07680751What this trial is testingEuropean Cystinosis Cohort 2Who this might be right forCystinosis Institut National de la Santé Et de la Recherche Médicale, France 250